Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Clinical and Translational Radiation Oncology|March 7, 2023
Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trialAmar U Kishan, Nicholas Marco, Ting Martin Ma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 3, 2022
Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapyTing Martin Ma, Jack Neylon, Maria Casado, et al.
Medical Physics|April 23, 2025
A clustering-based approach to address correlated features in predicting genitourinary toxicity from MRI-guided prostate SBRTPouyan Rezapoor, Jonathan Pham, Beth Neilsen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 7, 2015
Inositol Hexakisphosphate Kinase-3 Regulates the Morphology and Synapse Formation of Cerebellar Purkinje Cells via Spectrin/AdducinChenglai Fu, Jing Xu, Ruo-Jing Li, et al.
Cureus|March 12, 2026
A Silicone-Based Film-Forming Gel Wound Dressing for Radiation Dermatitis in Head and Neck Cancer Patients: A Retrospective Cohort Analysis Using Clinical InformaticsEulanca Y Liu, Erika Jank, P Travis Courtney, et al.
Applied Radiation Oncology|October 21, 2021
Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRTNeil R Parikh, Mary Ann Clark, Parashar Patel, et al.
JAMA Network Open|December 1, 2023
Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate CancerTing Martin Ma, Neeraj Agarwal, Brandon Mahal, et al.
Advances in Radiation Oncology|December 19, 2022
Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19Ting Martin Ma, Neil R Parikh, Rebecca G Philipson, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
Pageof 6